ACT Advisors, LLC.
- SEC CIK
- 0001842554
- Latest filing
- Jul 22, 2026
ACXP holding history
Acurx Pharmaceuticals, Inc. in every 13F filed by ACT Advisors, LLC., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
ACXP overviewAll 13F holders of ACXPFull Q2 2026 holdings
- Shares (Q3 2025)
- 0
- Sold out in Q3 2025
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 2
- Since Q4 2024
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q3 2025 | 0 | $0 | 0.0% | −2,298−100.0% | Sold outConverted for a 1-for-20 split | Holders |
| Q2 2025 | 45,952 | $23.5K | <0.1% | +45,952 | New | Holders |
| Q1 2025 | 0 | $0 | 0.0% | −21,284−100.0% | Sold out | Holders |
| Q4 2024 | 21,284 | $17.3K | <0.1% | +21,284 | New | Holders |